S'abonner

Effects of distance from a heavily transited avenue on asthma and atopy in a periurban shantytown in Lima, Peru - 11/08/11

Doi : 10.1016/j.jaci.2010.11.031 
Lauren M. Baumann, MHS a, b, Colin L. Robinson, BA a, b, Juan M. Combe, MD b, Alfonso Gomez, MD b, Karina Romero, MD b, Robert H. Gilman, MD b, c, d, Lilia Cabrera, RN b, Nadia N. Hansel, MD, MPH a, e, f, Robert A. Wise, MD a, f, Patrick N. Breysse, PhD, MHS f, Kathleen Barnes, PhD a, e, Juan E. Hernandez, PhD g, William Checkley, MD, PhD a, b, d,
a Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, Md 
b A.B. PRISMA, Lima, Peru 
c Program in Global Disease Epidemiology and Control, Department of International Health, Johns Hopkins University, Baltimore, Md 
d Departamento de Microbiología, Facultad de Ciencias y Filosofía, and the CRONICAS Center of Excellence for Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru 
e Division of Allergy and Clinical Immunology, Johns Hopkins School of Medicine, Baltimore, Md 
f Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md 
g Centro de Información para Decisiones en Salud Pública, Instituto Nacional de Salud Publica, Cuernavaca, Mexico 

Reprint requests: William Checkley, MD, PhD, Johns Hopkins University, Division of Pulmonary and Critical Care, 1830 Monument St, Fifth Floor, Baltimore, MD 21205.

Abstract

Background

Proximity to roadways increases the risk of asthma in developed countries; however, relatively little is known about this relationship in developing countries, where rapid and uncontrolled growth of cities has resulted in urban sprawl and heavy traffic volumes.

Objective

We sought to determine the effect of distance from a heavily transited avenue on asthma symptoms and quantitative respiratory outcome measures in a periurban shantytown in Lima, Peru.

Methods

We enrolled 725 adolescents aged 13 to 15 years who were administered a survey on asthma symptoms and measured spirometry, response to allergy skin testing, and exhaled nitric oxide (eNO). We calculated distances from the main avenue for all households and measured indoor particulate matter in 100 households. We used multivariable regression to model the risk of asthma symptoms, risk of atopy, eNO levels, and FEV1/forced vital capacity ratio as a function of distance.

Results

Compared against 384 meters, the odds of current asthma symptoms in households living within 100 meters increased by a factor of 2 (P < .05). The odds of atopy increased by a factor of 1.07 for every 100-meter difference in the distance from the avenue (P = .03). We found an inverse relationship in prebronchodilator FEV1/forced vital capacity and distance to the avenue in female subjects (P = .01) but not in male subjects. We did not find an association between eNO or household particulate matter levels and distance.

Conclusion

Living in close proximity to a high-traffic-density avenue in a periurban community in Peru was associated with a greater risk of asthma symptoms and atopy. Regulation of mobile-source pollutants in periurban areas of developing countries might help reduce the burden of asthma symptoms and atopy.

Le texte complet de cet article est disponible en PDF.

Key words : Asthma symptoms, atopy, distance, traffic, particulate matter, spirometry

Abbreviations used : BMI, eNO, FVC, ISAAC, NO2, PM, PM2.5, PM10


Plan


 Supported by a Johns Hopkins Center for Global Health Award (PI: Hansel) and the Fogarty International Center Training Grant (Grant R24 TW007988). W.C. was supported by a Clinician Scientist Award from the Johns Hopkins University, a K99/R00 Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute, National Institutes of Health, and by a contract (HHSN268200900033C) with the National Heart, Lung, and Blood Institute, National Institutes of Health. K.B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program. C.L.R. was a Fogarty International Clinical Research Scholar during the time of this work and was further supported by Tufts University School of Medicine. L.M.B. was supported by a predoctoral NIH T35 Training Grant (T35AI065385). Support for exposure measurements were provided by National Institute for Environmental Health Sciences grants ES015903 and ES03819. Additional support came from A.B. PRISMA and collaborators at JHU. Lincoln Diagnostics (Decatur, Ill) and ALK-Abelló (Round Rock, Tex) generously donated all skin prick atopy kits and antigens, respectively, used in this in this study. Aerocrine (New Providence, NJ) provided us, at discount, materials for eNO testing.
 Disclosure of potential conflict of interest: K. Barnes has received research support from the National Institutes of Health and Sanofi-Aventis. The rest of the authors have declared that they have no conflict of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 127 - N° 4

P. 875-882 - avril 2011 Retour au numéro
Article précédent Article précédent
  • The Editors’ Choice
  • Donald Y.M. Leung, Stanley J. Szefler, Associate Editors of the JACI
| Article suivant Article suivant
  • Host and viral factors associated with severity of human rhinovirus–associated infant respiratory tract illness
  • E. Kathryn Miller, John V. Williams, Tebeb Gebretsadik, Kecia N. Carroll, William D. Dupont, Yassir A. Mohamed, Laura-Lee Morin, Luke Heil, Patricia A. Minton, Kimberly Woodward, Zhouwen Liu, Tina V. Hartert

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.